Precision Biosciences Inc (DTIL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Sales | 13,120 | 19,789 | 8,780 | 10,598 | 7,363 |
| Gross Profit | 13,120 | 19,789 | 8,780 | 10,598 | 7,363 |
| Operating Expenses | 25,483 | 22,918 | 22,134 | 1,341 | 22,039 |
| Operating Income | -12,363 | -3,129 | -13,354 | 9,257 | -14,676 |
| Interest Expense | 576 | 553 | 522 | 486 | 405 |
| Other Income | 829 | 649 | -74 | -6,786 | -610 |
| Pre-tax Income | -12,110 | -3,033 | -13,950 | 1,985 | -15,691 |
| Net Income Continuous | -12,110 | -3,033 | -13,950 | 1,985 | -15,691 |
| Net Income Discontinuous | 4,031 | -8,858 | -11,110 | -30,473 | -8,255 |
| Net Income | $-8,079 | $-11,891 | $-25,060 | $-28,488 | $-23,946 |
| EPS Basic Total Ops | -2.10 | -3.13 | -6.75 | -3.87 | -6.61 |
| EPS Basic Continuous Ops | -3.15 | -0.80 | -3.76 | 6.94 | -4.25 |
| EPS Basic Discontinuous Ops | 1.05 | -2.33 | -2.99 | -10.98 | -2.24 |
| EPS Diluted Total Ops | -2.10 | -3.13 | -6.75 | -3.87 | -6.61 |
| EPS Diluted Continuous Ops | -3.15 | -0.80 | -3.76 | 6.94 | -4.25 |
| EPS Diluted Discontinuous Ops | 1.05 | -2.33 | -2.99 | -10.98 | -2.24 |
| EBITDA(a) | $-10,451 | $-839 | $-11,170 | $11,441 | $-12,518 |